Manager × security

RENAISSANCE TECHNOLOGIES LLC UTHR holdings history

Who else holds this security?

UNITED THERAPEUTICS CORP · CUSIP 91307C102 · CIK 1037389

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, RENAISSANCE TECHNOLOGIES LLC reported 1.71M UTHR (shares), valued at $925.85M, or 1.27% of its reported non-derivative portfolio. Filed 2026-08-13.

Verify history & sources
Portfolio weight and quantity history
Reported portfolio weight
1.27%
Shares
1.71M
1,708,739
Reported value
$925.85M
USD

Shares decreased 4.38%; reported value decreased 12.63%, and weight changed -0.39 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20261.27%1,708,739SEC filingFiled Aug 13, 2026
Q1 20261.66%1,787,019SEC filingFiled May 14, 2026
Q4 20251.44%1,909,259SEC filingFiled Feb 12, 2026
Q3 20251.20%2,173,392SEC filingFiled Nov 13, 2025
Q2 20250.81%2,119,092SEC filingFiled Aug 13, 2025
Q1 20250.98%2,106,992SEC filingFiled May 14, 2025
Q4 20241.09%2,089,392SEC filingFiled Feb 13, 2025
Q3 20241.16%2,155,392SEC filingFiled Nov 13, 2024
Q2 20241.17%2,174,692SEC filingFiled Aug 9, 2024
Q1 20240.78%2,151,714SEC filingFiled May 13, 2024
Q4 20230.74%2,170,214SEC filingFiled Feb 13, 2024
Q3 20230.87%2,250,508SEC filingFiled Nov 14, 2023

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q3 20230.87%2,250,508$508.32MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing
Filed Nov 14, 2023
Q4 20230.74%2,170,214$477.21MShares decreased 3.57%; reported value decreased 6.12%, and weight changed -0.13 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 13, 2024
Q1 20240.78%2,151,714$494.29MShares decreased 0.85%; reported value increased 3.58%, and weight changed +0.04 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 13, 2024
Q2 20241.17%2,174,692$692.75MShares increased 1.07%; reported value increased 40.15%, and weight changed +0.39 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 9, 2024
Q3 20241.16%2,155,392$772.38MShares decreased 0.89%; reported value increased 11.50%, and weight changed -0.01 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 13, 2024
Q4 20241.09%2,089,392$737.22MShares decreased 3.06%; reported value decreased 4.55%, and weight changed -0.07 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 13, 2025
Q1 20250.98%2,106,992$649.52MShares increased 0.84%; reported value decreased 11.90%, and weight changed -0.11 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 14, 2025
Q2 20250.81%2,119,092$608.92MShares increased 0.57%; reported value decreased 6.25%, and weight changed -0.17 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 13, 2025
Q3 20251.20%2,173,392$911.11MShares increased 2.56%; reported value increased 49.63%, and weight changed +0.39 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Nov 13, 2025
Q4 20251.44%1,909,259$930.29MShares decreased 12.15%; reported value increased 2.10%, and weight changed +0.24 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Feb 12, 2026
Q1 20261.66%1,787,019$1.06BShares decreased 6.40%; reported value increased 13.91%, and weight changed +0.22 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed May 14, 2026
Q2 20261.27%1,708,739$925.85MShares decreased 4.38%; reported value decreased 12.63%, and weight changed -0.39 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing
Filed Aug 13, 2026
RENAISSANCE TECHNOLOGIES LLC · UNITED THERAPEUTICS CORP

Take these holdings further.

This page includes 12 of 12 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1037389","quarter":"2026Q2","cusip":"91307C102"}

get_institutional_manager_history
{"cik":"1037389","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.